Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01259856
What this trial is testing

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Who this might be right for
High Risk Polycythemia VeraHigh Risk Essential Thrombocythemia
Ronald Hoffman 168
Large-scale testing (Phase 3)Active Not RecruitingNCT04320979
What this trial is testing

Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2,400
Not applicableUnknownNCT04771546
What this trial is testing

Efficacy of Intravaginal Carboxymethyl-β-glucan and Polycarbophil on Low-grade Cervical Lesions (GLUCANCIN)

Who this might be right for
Human Papilloma Virus
Uriach Consumer Healthcare 200
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)WithdrawnNCT02745756
What this trial is testing

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Who this might be right for
NeuroblastomaNeoplasms, Nerve Tissue
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00025246
What this trial is testing

Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 89
Large-scale testing (Phase 3)Study completedNCT00514488
What this trial is testing

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)

Who this might be right for
Chronic Myeloid Leukemia
University of Bologna
Early research (Phase 1)Looking for participantsNCT07723703
What this trial is testing

Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML

Who this might be right for
Acute Myeloid LeukaemiaHigh Risk Myelodysplastic Syndrome
Amphista Therapeutics Ltd 54
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Large-scale testing (Phase 3)Looking for participantsNCT06764238
What this trial is testing

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Who this might be right for
Acute Lymphoblastic Leukemia ALLChildhood Leukemia, Acute LymphoblasticB Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China 1,800
Large-scale testing (Phase 3)Ended earlyNCT05305040
What this trial is testing

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegalovirus Infections+3 more
AlloVir 451
Not applicableStudy completedNCT05824273
What this trial is testing

The INSPIRE-Lung Study

Who this might be right for
Lung Cancer
Hackensack Meridian Health 512
Not applicableUnknownNCT04781023
What this trial is testing

Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance

Who this might be right for
Human Papilloma Virus
Uriach Consumer Healthcare 200
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)Looking for participantsNCT05727761
What this trial is testing

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Who this might be right for
Oral Leukoplakia
University of Minnesota 36
Post-approval studies (Phase 4)Study completedNCT01907880
What this trial is testing

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 74
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Not applicableStudy completedNCT03344796
What this trial is testing

UV Exposure Assessed With Wearable Sensor and Sun Protection

Who this might be right for
Sunburn, ErythemaSun Protection
Northwestern University 164
Testing effectiveness (Phase 2)Ended earlyNCT01704027
What this trial is testing

Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Centre Georges Francois Leclerc 28
Very early researchLooking for participantsNCT06122896
What this trial is testing

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+2 more
Dana-Farber Cancer Institute 5,000
Next Page